ACCELERATING THE FIGHT AGAINST CANCER
Live / Registered — Registered (as of 23 Jan 2024)
What this means for you
Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Jan 2030: the §8 declaration of use).
Record
- Serial number
- 97447707
- Registration number
- 7290245
- Mark type
- Slogan / phrase
- Filed
- 07 Jun 2022
- Registered
- 23 Jan 2024
- Next maintenance filing
- §8 declaration of use, due by 23 Jan 2030 (grace period to 23 Jul 2030)
- Attorney of record
- Mark J. Burzych
Goods and services
- Class 005 — Pharmaceuticals: Medical radioisotopes for therapeutic or diagnostic use
- Class 040 — Treatment of materials: Custom manufacture of medical radioisotopes
- Class 042 — Scientific and technological services: Scientific research and development; Research and development in the field of medical radioisotopes
Owner
- Niowave, Inc., Lansing, MI, US
- Niowave, Inc., Lansing, MI, US
Prior registrations
Prosecution history
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 01 Aug 2023 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 31 Jul 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Jul 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jul 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Jun 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Jun 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Mar 2023 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
- 31 Mar 2023 — ASSIGNED TO LIE
- 31 Mar 2023 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 31 Mar 2023 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 31 Mar 2023 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 21 Mar 2023 — ASSIGNED TO EXAMINER